Clinical Efficacy of Xiaoyaosan Combined with Paroxetine Tablets in Treatment of Migraine with Liver Depression and Blood Deficiency Syndrome and Depression Based on Transcranial Doppler
|更新时间:2022-12-21
|
Clinical Efficacy of Xiaoyaosan Combined with Paroxetine Tablets in Treatment of Migraine with Liver Depression and Blood Deficiency Syndrome and Depression Based on Transcranial Doppler
Chinese Journal of Experimental Traditional Medical FormulaeVol. 29, Issue 2, Pages: 113-118(2023)
ZHANG Meng,WANG Meixia,ZHAO Qian,et al.Clinical Efficacy of Xiaoyaosan Combined with Paroxetine Tablets in Treatment of Migraine with Liver Depression and Blood Deficiency Syndrome and Depression Based on Transcranial Doppler[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(02):113-118.
ZHANG Meng,WANG Meixia,ZHAO Qian,et al.Clinical Efficacy of Xiaoyaosan Combined with Paroxetine Tablets in Treatment of Migraine with Liver Depression and Blood Deficiency Syndrome and Depression Based on Transcranial Doppler[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(02):113-118. DOI: 10.13422/j.cnki.syfjx.20230195.
Clinical Efficacy of Xiaoyaosan Combined with Paroxetine Tablets in Treatment of Migraine with Liver Depression and Blood Deficiency Syndrome and Depression Based on Transcranial Doppler
Based on the hemodynamic indicators of transcranial Doppler (TCD),this study aimed to analyze the correlations of visual analogue scale(VAS) and Hamilton depression rating scale 24-item(HAMD-24) scores with mean blood velocity (Vm) of the anterior cerebral artery (ACA),the middle cerebral artery (MCA), and the posterior cerebral artery (PCA),and the correlation between VAS score of headache and HAMD-24 score,and explore the clinical efficacy of Xiaoyaosan combined with paroxetine tablets in the treatment of migraine with liver depression and blood deficiency syndrome and depression.
Method
2
Sixty-two outpatients treated in the encephalopathy department, the First Afffiliated Hospital of Anhui University of Chinese Medicine between January 2019 to June 2020 who were in line with the diagnostic criteria were enrolled and divided into a treatment group (32 cases) and a control group (30 cases). All patients were treated with paroxetine tablets,while those in the treatment group received additional Xiaoyaosan. The changes in relevant indicators in the two groups before and after treatment were observed. The effects of Xiaoyaosan on the TCD indicators (Vm
ACA
, Vm
MCA
, and Vm
PCA
), scores of migraine and depression [including VAS score, Headache Impact Test-6 (HIT-6) score,and HAMD-24 score], and the traditional Chinese medicine (TCM) syndrome score were analyzed.
Result
2
VAS and HAMD-24 scores were positively correlated with Vm
ACA
, Vm
MCA
, and Vm
PCA
(
P
<
0.01). VAS scores were positively correlated with HAMD-24 scores. Compared with the conditions before treatment, the levels of TCD indicators (Vm
ACA
, Vm
MCA
, and Vm
PCA
) in the two groups decreased after treatment (
P
<
0.01), and the scores of HIT-6, VAS, and HAMD-24 in the two groups were significantly improved (
P
<
0.01). Compared with the control group after treatment, the treatment group showed decreased levels of TCD indicators (Vm
ACA
, Vm
MCA
, and Vm
PCA
) (
P
<
0.01) and superior improvement of HIT-6, VAS, and HAMD-24 scores (
P
<
0.01). The effective rate in the treatment group was 90.6% (29/32), higher than 63.3% (19/30) in the control group (
χ
2
=5.13,
P
<
0.05). There was no significant difference in adverse reactions between the two groups.
Conclusion
2
TCD indicators can effectively reflect the cerebral blood flow of patients with migraine and depression co-morbidity,and migraine is correlated with the onset and severity of depression. The comprehensive analysis showed that the efficacy of Xiaoyaosan combine paroxetine tablets was better than that of paroxetine tablets alone in the treatment of migraine with liver depression and blood deficiency syndrome and depression. This therapeutic protocol can significantly improve cerebral blood flow and the symptoms and degree of migraine and depression and can provide references for clinical treatment.
VETVIK K G , MACGREGOR E A . Sex differences in the epidemiology,clinical features,and pathophysiology of migraine [J]. Lancet Neurol , 2017 , 16 ( 1 ): 76 - 87 .
YU S , LIU R , ZHAO G , et al . The prevalence and burden of primary headaches in China:A population-based door-to-door survey [J]. Headache , 2012 , 52 ( 4 ): 582 - 591 .
WHITEFORD H A , DEGENHARDT L , REHM J , et al . Global burden of disease attributable to mental and substance use disorders:Findings from the Global Burden of Disease Study 2010 [J]. Lancet , 2013 , 382 ( 9904 ): 1575 - 1586 .
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators . Global,regional,and national incidence,prevalence,and years lived with disability for 310 diseases and injuries,1990‐2015:A systematic analysis for the Global Burden of Disease Study 2015 [J]. Lancet , 2016 , 388 ( 10053 ): 1545 - 1602 .
SCHUR E A , NOONAN C , BUCHWALD D , et al . A twin study of depression and migraine:Evidence for a shared genetic vulnerability [J]. Headache , 2009 , 49 ( 10 ): 1493 - 1502 .
BRESLAU N , LIPTON R B , STEWART W F , et al . Comorbidity of migraine and depression:Investigating potential etiology and prognosis [J]. Neurology , 2003 , 60 ( 8 ): 1308 - 1312 .
Headache classification committee of the international headache society (IHS) The international classification of headache disorders,3 rd edition [J]. Cephalalgia , 2018 , 38 ( 1 ): 1 - 211 .
DAI Y F , XIAO Z P . Chinese classification of mental disorders is compared with CCMD-3 and ICD-10 [J]. J Clin Psychiatry , 2013 , 23 ( 6 ): 426 - 427 .
SON M J , CHOI S , KIM Y E , et al . Herbal medicines for the treatment of otitis media with effusion:A systematic review of randomised controlled trials [J]. BMJ Open , 2016 , 6 ( 11 ): 250 - 253 .
BLAAUW B A , DYB G , HAGEN K , et al . The relationship of anxiety,depression and behavioral problems with recurrent headache in late adolescence-a Young-HUNT follow-up study [J]. J Headache Pain , 2015 , 16 : 10 .
Herbal Cake-separated Moxibustion Improves Cognitive Function in Rat Model of Chronic Fatigue Syndrome via PI3K/Beclin1 Signaling Pathway
Clinical and Mechanism of Modified Xiaoyaosan and Its Effective Components in Treatment of Thyroid Diseases: A Review
Mechanism of Herbal Cake-separated Moxibustion in Improving Neuroimmune Inflammation in Rats with Chronic Fatigue Syndrome by Interfering TLR4/MyD88/NF-κB Pathway
Xiaoyaosan Regulates HPT Axis in Rat Model with Syndrome of Liver Depression and Spleen Deficiency via CGA/GPX2/TSHβ Pathway for Thyroid Hormone Synthesis
Effect of Borneol on Pharmacodynamics,Pharmacokinetics and Brain Tissue Distribution of Main Active Ingredients of Jiaotaiwan in Depression Model Rats
Related Author
ZHAI Chuntao
HOU Yawei
SHI Linjuan
WANG Yixiao
TIAN Yuefeng
LI Shanshan
FU Yu
WEI Dandan
Related Institution
Second Clinical College of Shanxi University of Chinese Medicine
First Affiliated Hospital of Henan University of Chinese Medicine
The First Clinical Medical College of Henan University of Chinese Medicine
Guangxi University of Chinese Medicine
Guangxi Key Laboratory of Chinese Medicine Foundation Research, Guangxi University of Chinese Medicine